LGALS3 and heart failure: Similarly, this alteration was also observed in the study by Deveci et al. in 112 patients with heart failure (EF < 35%) during 6 months of spironolactone treatment; the galectin-3 concentration decreased from 39 ± 21 ng/mL to 33 ± 22 ng/mL [6].